Richard Horton on the Oxford vaccine phase 3 trial
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
